💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for Brainstorm Cell Therapeutics Inc. (BCLI)
« Back to company indexBCLI Chatter Timeline
Stock Ticker for BCLI
Most Active Tweeters for BCLI
| User | Tweets |
|---|---|
| @Tickeron | 6 |
| @investor_feed | 2 |
| @KentrilBrand | 2 |
| @EdgarInsider | 2 |
| @MarcJacksonLA | 2 |
Recent Tweets for BCLI
 |
@Tickeron $BCLI's 10-day Moving Average moved below its 50-day Moving Average on April 25, 2022. View odds for this and other… https://t.co/RuSTVHnVrc May 27th 2022, 2:05am |
 |
@khmerxbxboi FDA TRIAL BIOTECH this month = $BCLI https://t.co/KOxm2SqmhG May 26th 2022, 12:05am |
 |
@MaisaCorp BrainStorm Cell Therapeutics Inc $BCLI : Use of cerebrospinal fluid biomarkers to interrogate multiple neuroinflam… https://t.co/a1vLDLKPkn May 25th 2022, 10:05pm |
 |
@MarcJacksonLA $BCLI BCLI: Anticipating News on How NurOwn® Will be Advanced Forward… - Benzinga https://t.co/dfyKaqFXDx May 25th 2022, 2:05pm |
|
@khmerxbxboi FDA TRIAL BIOTECH = Like if you bullish on $BCLI #StockMarket #Monkeypoxalypse https://t.co/KOxm2SqmhG May 24th 2022, 9:05pm |
 |
@ZacksSmallCap $BCLI: @BrainstormCell - Anticipating News On How NurOwn® Will Be Advanced Forward… - https://t.co/CctoK6SHmG by… https://t.co/TPiQwMtPJP May 24th 2022, 3:05pm |
 |
@OracleNYSE $BCLI $14 PT Zacks out May 24th 2022, 2:05pm |
|
@Tickeron $BCLI's 10-day Moving Average moved below its 50-day Moving Average on April 25, 2022. View odds for this and other… https://t.co/k64axZrE26 May 22nd 2022, 10:05am |
 |
@DAYTRAD16724184 $BCLI Earnings reports today before the markets open...https://t.co/sFqZv8FS2r May 22nd 2022, 2:05am |
|
@Tickeron $BCLI's 10-day Moving Average broke below its 50-day Moving Average on April 25, 2022. View odds for this and other… https://t.co/lHaZu1aH43 May 21st 2022, 10:05pm |
 |
@hesham_monica $BCLI (NASDAQ) Stock Rating Changed to Strong Buy: Brainstrom Cell Therapeutics >> https://t.co/6EQLc9WKfK May 18th 2022, 11:05am |
 |
@mediasentiment $BCLI new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 293 May 17th 2022, 1:05pm |
 |
@newsfilterio BrainStorm Cell Therapeutics Announces First Quarter 2022 Financial Results and Provides a Corporate Update $BCLI https://t.co/0npp7E03EF May 17th 2022, 6:05am |
 |
@StocksoftheDay_ $BCLI News Screener Alert: The price is up after the recent publication posted about 7 hours ago .… https://t.co/P4NgkaQeMr May 16th 2022, 6:05pm |
 |
@TheTradingBlvd Brainstorm Cell Therapeutics Inc.'s (BCLI) CEO Chaim Lebovits on Q1 2022 Results - Earnings Call Transcript $BCLI https://t.co/AUuJ6Bo4K3 May 16th 2022, 2:05pm |
 |
@SeekingAlpha $BCLI - Brainstorm Cell Therapeutics Inc.'s (BCLI) CEO Chaim Lebovits on Q1 2022 Results - Earnings Call Transcript… https://t.co/ohoQcfXv4O May 16th 2022, 2:05pm |
|
@MarcJacksonLA $BCLI BrainStorm Cell Therapeutics Announces First Quarter 2022 Financial Results and Provides a Corporate Update https://t.co/HMQxLDwrh2 May 16th 2022, 12:05pm |
 |
@KentrilBrand RT @Tickeron: $BCLI's 10-day Moving Average broke below its 50-day Moving Average on April 25, 2022. View odds for this and other indicator… May 16th 2022, 12:05pm |
|
@Tickeron $BCLI's 10-day Moving Average moved below its 50-day Moving Average on April 25, 2022. View odds for this and other… https://t.co/oTo1JXA7xI May 16th 2022, 12:05pm |
|
@Tickeron $BCLI's 10-day Moving Average broke below its 50-day Moving Average on April 25, 2022. View odds for this and other… https://t.co/ulNcG3V3VX May 16th 2022, 12:05pm |
|
@KentrilBrand RT @Tickeron: Brainstorm Cell Therapeutics to report earnings on May 16, 2022. Earnings per share (EPS) estimate: $-0.29 $BCLI #BrainstormC… May 16th 2022, 12:05pm |
|
@Tickeron Brainstorm Cell Therapeutics to report earnings on May 16, 2022. Earnings per share (EPS) estimate: $-0.29 $BCLI… https://t.co/TIWdYmIxGS May 16th 2022, 12:05pm |
 |
@EdgarInsider Alert [Quarterly Report] / Form 10-Q filed with the SEC $BCLI BRAINSTORM CELL THERAPEUTICS INC. https://t.co/95YxLqXgWN May 16th 2022, 11:05am |
|
@newsfilterio Recap: Brainstorm Cell Q1 Earnings $BCLI https://t.co/UUdD8nd1K3 May 16th 2022, 11:05am |
 |
@BenzingaMedia $BCLI, $BCLI Recap: Brainstorm Cell Q1 Earnings - https://t.co/QKWCH4vJsf May 16th 2022, 11:05am |
 |
@investor_feed $BCLI 10-Q Brainstorm Cell Therapeutics (16 May, 7:30am) ? 2022 Q1 Earnings https://t.co/i2XNmX9pj7 #BCLI… https://t.co/du0wEJ3VOy May 16th 2022, 11:05am |
 |
@bthefirsttoknow First out// $BCLI: Recap: Brainstorm Cell Q1 Earnings https://t.co/r5OvoApLky May 16th 2022, 11:05am |
 |
@FintelAlerts $BCLI / Brainstorm Cell Therapeutics files form 10-Q https://t.co/5ZpRmuENXF May 16th 2022, 11:05am |
|
@EdgarInsider Filing Alert, FORM 8-K [Press/News Current Report] available. $BCLI BRAINSTORM CELL THERAPEUTICS INC. https://t.co/hk6YGTVucJ May 16th 2022, 11:05am |
|
@investor_feed $BCLI 8-K Brainstorm Cell Therapeutics (16 May, 7:16am) ? BrainStorm Cell Therapeutics Announces First Quarter… https://t.co/bBtOGENKCO May 16th 2022, 11:05am |
 |
@Market_Newswire $BCLI SEC Filing: 8-K Earnings - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) May 16 https://t.co/nYy2OLnAnl May 16th 2022, 11:05am |
 |
@FlashAlert_me $BCLI [15s. delayed, acc.~90%, always check] Earnings Release May 16, 07:05:00: https://t.co/7o8wbxhNEy May 16th 2022, 11:05am |
|
@FlashAlert_me $BCLI [15s. delayed]: Issued Press Release on May 16, 07:05:00: BrainStorm Cell Therapeutics Announces First Quarte… https://t.co/Y0fExq1p44 May 16th 2022, 11:05am |
|
@mediasentiment $BCLI new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 168 May 16th 2022, 11:05am |
 |
@StockNewsBot2 $BCLI BrainStorm Cell Therapeutics Announces First Quarter 2022 Financial Results and Provides a Corporate Update https://t.co/dg4fTNs7Gj May 16th 2022, 11:05am |
 |
@stock_titan $BCLI BrainStorm Cell Therapeutics Announces First Quarter 2022 Financial Results and Provides a Corporate Update https://t.co/HR7NC5fZJt May 16th 2022, 11:05am |
 |
@TheMarketsDaily Brainstorm Cell Therapeutics $BCLI Coverage Initiated by Analysts at https://t.co/yG4TZ5D4qh https://t.co/dsJvDYD4Xa May 15th 2022, 2:05pm |
|
@BenzingaMedia $BCLI, $BCLI Brainstorm Cell Earnings Preview - https://t.co/InG3yAQUHZ May 13th 2022, 2:05pm |
|
@bthefirsttoknow First out// $BCLI: Brainstorm Cell Earnings Preview https://t.co/A3TRG8Nc1U May 13th 2022, 2:05pm |
|
@Tickeron $BCLI in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/6vpScRIIVo May 12th 2022, 4:05pm |
|
@Tickeron Brainstorm Cell Therapeutics to report earnings on May 13, 2022. Earnings per share (EPS) estimate: $-0.29 $BCLI… https://t.co/jpjwUi0ZHj May 12th 2022, 3:05pm |
|
@FlashAlert_me $BCLI [15s. delayed]: Issued Press Release on May 12, 08:02:00: BrainStorm Strengthens Executive Team with Key Appo… https://t.co/rGQ6MO2sa5 May 12th 2022, 12:05pm |
|
@StockNewsBot2 $BCLI BrainStorm Strengthens Executive Team with Key Appointments in R&D and Legal https://t.co/qfGg8brEOv May 12th 2022, 12:05pm |
|
@stock_titan $BCLI BrainStorm Strengthens Executive Team with Key Appointments in R&D and Legal https://t.co/E4wniFJaXj May 12th 2022, 12:05pm |
|
@newsfilterio BrainStorm Strengthens Executive Team with Key Appointments in R&D and Legal $BCLI https://t.co/KRYcneaLus May 12th 2022, 12:05pm |
 |
@WebChronicleTo1 $BCLI BrainStorm Strengthens Executive Team with Key Appointments in R&D and Legal https://t.co/DbNRLTUFHr May 12th 2022, 12:05pm |
 |
@ahighelevation $BCLI SNP Associates with NurOwn Activity in ALS Phase 3 Trial #ALS #multiplesclerosis - https://t.co/s84zIbIpKX https://t.co/KVjzN2DDrV May 9th 2022, 8:05pm |
 |
@JodyPressman @derekgunz How? Because that’s how @Cylebo is running the show $BCLI May 6th 2022, 11:05pm |
|
@Tickeron $BCLI in -3% Downtrend, sliding for three consecutive days on May 3, 2022. View odds for this and other indicators:… https://t.co/HzPx8vzfW6 May 5th 2022, 11:05pm |
 |
@mometicmobile Unusual-15min-MOMO: BCLI, AKTS only from Mometic $BCLI,AKTS May 4th 2022, 7:05pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.